Luna Innovations (LUNA) vs. Tenax Therapeutics (TENX) Financial Review

Tenax Therapeutics (NASDAQ:TENX) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Tenax Therapeutics and Luna Innovations, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenax Therapeutics 0 0 0 0 N/A
Luna Innovations 0 1 2 0 2.67

Luna Innovations has a consensus target price of $4.50, indicating a potential downside of 0.44%. Given Luna Innovations’ higher possible upside, analysts plainly believe Luna Innovations is more favorable than Tenax Therapeutics.

Earnings & Valuation

This table compares Tenax Therapeutics and Luna Innovations’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tenax Therapeutics N/A N/A -$6.81 million N/A N/A
Luna Innovations $42.92 million 2.96 $11.00 million $0.04 113.00

Luna Innovations has higher revenue and earnings than Tenax Therapeutics.

Profitability

This table compares Tenax Therapeutics and Luna Innovations’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tenax Therapeutics N/A -88.10% -79.88%
Luna Innovations 22.56% 5.65% 4.62%

Institutional & Insider Ownership

8.4% of Tenax Therapeutics shares are held by institutional investors. Comparatively, 22.5% of Luna Innovations shares are held by institutional investors. 10.4% of Tenax Therapeutics shares are held by company insiders. Comparatively, 11.2% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

Tenax Therapeutics has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500.

Summary

Luna Innovations beats Tenax Therapeutics on 9 of the 10 factors compared between the two stocks.

About Tenax Therapeutics

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

About Luna Innovations

Luna Innovations Incorporated develops, manufactures, and markets fiber optic sensing, and test and measurement products worldwide. It operates in two segments, Products and Licensing, and Technology Development. The Products and Licensing segment offers fiber optic sensing products, as well as test and measurement products to monitor the integrity of fiber optic network components and sub-assemblies, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and distributed sensing systems comprising optical distributed sensor interrogator sensing solution with multiple sensors whose inputs are integrated through a fiber optic network and software. This segment also offers optoelectronic solutions for various applications, such as metrology, missile guidance, flame monitoring, temperature sensing, particle detection, color sensing, infrared detection, and other applications; and terahertz sensing systems, which are used to measure and verify physical properties online and in real-time. In addition, this segment conducts applied research in the fiber optic sensing area for corporate and government customers. The Technology Development segment provides applied research for customers principally in the areas of sensing and instrumentation, advanced materials, and health sciences. The company sells its products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was founded in 1990 and is headquartered in Roanoke, Virginia.

Receive News & Ratings for Tenax Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenax Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.